Literature DB >> 32606405

Forkhead BioTherapeutics: developing a diabetes pill.

Eric Bender.   

Abstract

Entities:  

Keywords:  Biotechnology; Cell biology; Diabetes; Drug discovery

Year:  2020        PMID： 32606405     DOI： 10.1038/d41586-020-01801-y

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling.

Authors:  Fanny Langlet; Rebecca A Haeusler; Daniel Lindén; Elke Ericson; Tyrrell Norris; Anders Johansson; Joshua R Cook; Kumiko Aizawa; Ling Wang; Christoph Buettner; Domenico Accili
Journal:  Cell       Date:  2017-10-19       Impact factor: 41.582

2.  FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures.

Authors:  Ryotaro Bouchi; Kylie S Foo; Haiqing Hua; Kyoichiro Tsuchiya; Yoshiaki Ohmura; P Rodrigo Sandoval; Lloyd E Ratner; Dieter Egli; Rudolph L Leibel; Domenico Accili
Journal:  Nat Commun       Date:  2014-06-30       Impact factor: 14.919
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.